title: Euglycemic Ketoacidosis Caused by Sodium-Glucose Cotransporter 2 Inhibitors: A Case Report.
authors.affiliation: From Cleveland Clinic Florida, Weston, Florida, and University of California, Los Angeles, Los Angeles, California.
authors.forename: Shane A
authors.initials: SA
authors.lastname: Bobart
authors.affiliation: From Cleveland Clinic Florida, Weston, Florida, and University of California, Los Angeles, Los Angeles, California.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Gleason
authors.affiliation: From Cleveland Clinic Florida, Weston, Florida, and University of California, Los Angeles, Los Angeles, California.
authors.forename: Nydia
authors.initials: N
authors.lastname: Martinez
authors.affiliation: From Cleveland Clinic Florida, Weston, Florida, and University of California, Los Angeles, Los Angeles, California.
authors.forename: Keith
authors.initials: K
authors.lastname: Norris
authors.affiliation: From Cleveland Clinic Florida, Weston, Florida, and University of California, Los Angeles, Los Angeles, California.
authors.forename: Sandra F
authors.initials: SF
authors.lastname: Williams
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D000068896:Canagliflozin / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007662:Ketosis / Q000097:blood* / Q000139:chemically induced*; D000069450:Liraglutide / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D000068896:Canagliflozin; D000069450:Liraglutide; D008687:Metformin